A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers
Clinical trial NCT03258515 · COMPLETED
Trial details
- NCT number
- NCT03258515
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-03-24
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.